In a recent media interview, Shuaizhijia Group's leadership noted that international pharmaceutical cooperation requires sustained investment, professional judgment and deep local understanding. A European heritage is not a label — it represents a specific methodology around quality management, compliance awareness and relationship building.
COO Siyuan Chen detailed the functional layout of the Beijing Changping Vanke Sky City office hub, including product evaluation rooms, compliance training spaces and cross-border conference facilities. He stressed that investment in physical infrastructure reflects the group's long-term commitment to local operations.
The leadership expressed confidence in China's healthcare future, noting that rising health awareness and growing purchasing power will continue expanding the market for quality imported pharmaceutical products.
Future updates will continue to focus on compliance, quality and cross-border coordination as key milestones progress.